Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03066687 · ClinicalTrials.gov registry record · Phase 1
A Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy Participants
A Phase 1 study, sponsored by Janssen Research & Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT03066687 is a Phase 1 study that has completed, run by Janssen Research & Development. The registered enrollment target is 16 participants.
The verdict
NCT03066687, a Phase 1 study, has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The primary purpose of this study is to evaluate the effect of food on the relative bioavailability of a single 9 milligram (mg) oral dose of erdafitinib in healthy participants.
Interventions
- DRUG Erdafitinib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-03-14 |
| Est. Completion | 2017-05-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03066687
The ClinicalTrials.gov registry entry for NCT03066687 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Erdafitinib is the first listed.
NCT03066687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03066687 about?
NCT03066687 is a clinical study titled "A Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy Participants". The primary purpose of this study is to evaluate the effect of food on the relative bioavailability of a single 9 milligram (mg) oral dose of erdafitinib in healthy participants.
What is the current status of trial NCT03066687?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2017-03-14. Estimated completion is 2017-05-12.
What interventions are being tested in trial NCT03066687?
The interventions under investigation include: Erdafitinib (DRUG).
Who is sponsoring clinical trial NCT03066687?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.